Our work
Our work reflects the markets we operate within, and the mix of challenges faced. We work with numerable Governments on health reform, with insurers seeking to offer better protection products, with hospitals seeking to improve care and with a wide range of development organisations seeking to strengthen systems.
Case studies
Private Health Insurance Market assessment and product development advisory support
Multinational US Health Insurer | Private Health Insurance Market assessment and product development advisory support
| Hong Kong and Singapore
Introduction of case management and second medical opinion services
Multinational Life Insurance company | Introduction of case management and second medical opinion services | Multiple markets across Asia
Development of a non-communicable disease strategy for Asia
Asia Development Bank | Development of a non-communicable disease strategy for Asia | Asia-Pacific
Cancer Care Study and White Paper Submission
Pharma Consortium | Cancer Care Study and White Paper Submission | Hong Kong
Hospital growth strategy and development support
Private Hospital Group | Growth strategy and development support | Singapore
Health Insurance market research and product development advisory
Large pan-Asia life insurance company | Market research and product development advisory | Indonesia
Novel health financing review for pharmaceuticals across Asia
Multinational pharmaceutical company | Novel health financing review across Asia | Asia
Market assessment and commercialisation support for healthcare products and services
FTSE-Listed services firm | Market assessment and commercialisation support for healthcare products and services | Asia (Regional)
Strategic review of cardiac services in Fiji
World Health Organisation | Strategic review of cardiac services in Fiji | Fiji
Health advisory to the Government of Vietnam on UHC and health system design
Government of Vietnam | Health advisory to the Government of Vietnam on UHC and health system design | Vietnam
Scoping opportunities and market access for UK companies in Hong Kong's health system
UK Government | Healthcare Market assessment and analysis of areas of opportunity for UK companies | Hong Kong
Assessment of transparency in improving the health system in Hong Kong
BUPA | Assessment of the role transparency could play in improving the health system in Hong Kong | Hong Kong
Commercialisation support for a new digital telemedicine hub
PE Firm | Market assessment and commercialisation support for a new digital telemedicine hub | Hong Kong and China
Quantifying the economic and clinical impact of stress on health systems
CIGNA | Quantifying the economic and clinical impact of stress on health systems | Multi-country study
Scoping the potential for insurer-pharma partnerships
Multinational pharmaceutical firm | Insurer-pharma partnerships study | Asia
Development support for Hong Kong's first private not-for-profit teaching hospital
University Hospital | Development support for Hong Kong's first private not-for-profit teaching hospital | Hong Kong
Osteoporosis and Aged care strategy initiatives
Pharmaceutical Firm | Osteoporosis and Aged care strategy initiatives | Asia